Subgroup Analysis. Key efficacy and safety results will be summarized across subgroups defined by age group (3 – < 24 months, 2 years to 11 years, 12 to < 18 years).
Appears in 1 contract
Sources: Clinical Study Protocol
Subgroup Analysis. Key efficacy and safety results will be summarized across subgroups defined by age group (3 – < 24 months, 2 years to 11 years, 12 to < 18 yearsmonths old and ≥ 24 months old).
Appears in 1 contract
Sources: Clinical Study Protocol